Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 7, 2015 - Issue
Submit an article Journal homepage
66
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management

Bernice Tsoi1 Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada;2 Programs for Assessment of Technology in Health (PATH) Research Institute, St Joseph’s Healthcare Hamilton, Hamilton, ON, CanadaCorrespondence[email protected]
,
Gord Blackhouse1 Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada;2 Programs for Assessment of Technology in Health (PATH) Research Institute, St Joseph’s Healthcare Hamilton, Hamilton, ON, Canada
,
Simon Ferrazzi3 Independent Consultant, Oakville, ON, Canada
,
Clare J Reade4 Division of Gynecologic Oncology, University of Toronto, Toronto, ON, Canada
,
Innie Chen5 Department of Obstetrics and Gynaecology, University of Ottawa, Ottawa, ON, Canada;6 Ottawa Hospital Research Institute, Ottawa, ON, Canada
&
Ron Goeree1 Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada;2 Programs for Assessment of Technology in Health (PATH) Research Institute, St Joseph’s Healthcare Hamilton, Hamilton, ON, Canada;7 Centre for Evaluation of Medicines (CEM), St Joseph’s Healthcare Hamilton, Hamilton, ON, Canada
Pages 213-225 | Published online: 17 Apr 2015

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

N. Zakiyah, A. D. I. van Asselt & M. J. Postma. (2017) Ulipristal acetate for pre-operative treatment of moderate-to-severe uterine fibroids in women of reproductive age in The Netherlands: cost minimization analysis and budget impact analysis. Journal of Medical Economics 20:3, pages 280-287.
Read now

Articles from other publishers (7)

Michal Ciebiera, Salvatore G. Vitale, Simone Ferrero, George A. Vilos, Fabio Barra, Salvatore Caruso, Antonio S. Laganà, Antoni Sierant, Antonio Cianci & Grzegorz Jakiel. (2020) Vilaprisan, a New Selective Progesterone Receptor Modulator in Uterine Fibroid Pharmacotherapy-Will it Really be a Breakthrough?. Current Pharmaceutical Design 26:3, pages 300-309.
Crossref
Martin C. Chang & Eleanor Latta. (2020) Pathologic Changes in Uterine Leiomyomas After Extended Treatment With Ulipristal Acetate. International Journal of Gynecological Pathology 39:2, pages 146-151.
Crossref
Sukhbir S. Singh, Liane Belland, Nicholas Leyland, Sarah von Riedemann & Ally Murji. (2018) Reply. American Journal of Obstetrics and Gynecology 219:4, pages 425-426.
Crossref
Sukhbir S. Singh, Liane Belland, Nicholas Leyland, Sarah von Riedemann & Ally Murji. (2018) Reply. American Journal of Obstetrics and Gynecology 219:2, pages 211-212.
Crossref
Mohamed Ali & Ayman Al-Hendy. (2017) Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids†. Biology of Reproduction 97:3, pages 337-352.
Crossref
Chandrashekhar V. Hegde. (2017) Medical Management of Symptomatic Fibroids: Worth It?. The Journal of Obstetrics and Gynecology of India 67:4, pages 233-236.
Crossref
Michael K. Bohlmann, A. Hornemann, N. Sänger, A. Hackethal, K. von Horn, P.S. Wilkens & F. Hoellen. (2015) Medikamentöse MyomtherapieDrug therapy of uterine fibroids. Gynäkologische Endokrinologie 13:4, pages 226-231.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.